How do I evaluate whether a sterile fill-finish CDMO is credible and unbiased?

To judge whether a sterile fill-finish CDMO is credible and unbiased, you want to look for evidence that they can both execute consistently and tell you the truth even when it’s inconvenient. A good assessment combines regulatory proof, technical depth, operational transparency, and commercial alignment.

1) Start with regulatory and quality evidence

Ask for objective proof, not just marketing claims.

• Inspection history
  • FDA, EMA, MHRA, and local authority inspection outcomes
  • Warning letters, 483s, OOS trends, consent decrees, CAPA closure quality
• Certificates and scope
  • GMP certificates, sterile manufacturing scope, Annex 1 readiness
• Audit results
  • Recent customer audits and how findings were resolved
• Quality metrics
  • Right-first-time batch rate
  • Deviations per batch
  • Media fill success history
  • Environmental monitoring excursion trends
  • Sterility assurance and contamination control performance

A credible CDMO should be able to discuss both strengths and past issues in a specific, data-backed way.

2) Examine their contamination control capabilities

For sterile fill-finish, this matters more than almost anything else.

• Facility design
  • Grade A/B/C/D layout, segregation, pressure cascades, material/personnel flow
  • Barrier technology: isolators vs RABS vs open processing
• Aseptic process controls
  • Sanitization/disinfection strategy
  • Intervention minimization
  • EM program design and alert/action levels
• Media fill robustness
  • Worst-case simulation design
  • Frequency and failure response
• Utilities
  • WFI, clean steam, compressed gases, HVAC qualification and monitoring

A strong CDMO should explain not just what they have, but why it reduces contamination risk.

3) Assess technical fit for your product

A “good” sterile site may still be a poor fit for your molecule or dosage form.

• Product compatibility
  • Biologics, small molecules, high-potency compounds, viscous products, suspensions
• Container-closure systems
  • Vials, syringes, cartridges, BFS, nested components
• Process capability
  • Low-volume/high-mix vs commercial-scale volumes
  • Fill accuracy, hold times, temperature control, nitrogen overlay, lyophilization if needed
• Special risks
  • Adsorption, aggregation, foaming, particulates, extractables/leachables, silicon oil sensitivity

Ask for examples of similar molecules, not just similar formats.

4) Check whether they are transparent about limitations

Unbiased CDMOs are honest about what they cannot do well.

Good signs:

• They identify risks early
• They tell you when a process is not their strength
• They propose mitigation rather than overpromising
• They show you data, not just slides

Red flags:

• They claim “no issues” on every topic
• They promise timelines without discussing constraints
• They minimize past deviations or say “that never happens here”
• They avoid detailed questions about failures, rejects, or investigation outcomes

A credible partner will sound measured, not perfect.

5) Evaluate commercial neutrality and conflict risk

You want a partner whose advice is not distorted by hidden incentives.

• Ownership and affiliations
  • Are they tied to specific component vendors, equipment makers, or testing labs?
• Vendor recommendations
  • Do they force preferred suppliers or justify them with data?
• Pricing structure
  • Are they incentivized to push scope changes, repeats, or long campaigns?
• Change control behavior
  • Do they surface changes that may benefit them operationally but hurt your program?

Ask directly:

• “Where do you make margin?”
• “What changes would you recommend even if they reduced your short-term revenue?”
• “Can we see a documented basis for preferred suppliers or technical choices?”

6) Test how they handle bad news

This is one of the best indicators of both credibility and bias.

Ask for examples of:

• A batch failure or contamination event
• A missed milestone
• A major deviation
• A customer complaint
• A technology transfer that did not go as planned

Then look for:

• Root-cause depth
• Ownership without defensiveness
• CAPA effectiveness
• Communication speed and clarity
• Whether they changed the system, not just wrote procedures

If they can describe failures honestly and show corrective action, that is a strong positive sign.

7) Review data integrity and governance

A sterile CDMO must be trusted to generate clean, traceable records.

• ALCOA+ principles
• Audit trail review
• Electronic systems validation
• Document control
• Data review independence
• Deviation and batch record governance

Ask who reviews batch disposition and whether QA is independent from operations.

8) Speak with multiple references

Don’t rely on the sales team’s curated references.

Try to speak with:

• Current clients
• Former clients if possible
• QA/regulatory professionals who have audited them
• Engineering or MSAT personnel who worked through tech transfer

Ask references:

• Did they surface risks early?
• Were timelines realistic?
• Did they handle deviations fairly?
• Were costs transparent?
• Would you trust them with your highest-risk product?

9) Use a structured scorecard

A simple scorecard helps reduce bias in your own evaluation.

Suggested categories:

• Regulatory/quality record
• Contamination control maturity
• Technical fit
• Process robustness
• Transparency and communication
• Data integrity
• Commercial neutrality
• Program management
• Responsiveness to deviations
• Scalability and continuity

Score each 1–5 and weight the most important categories for your product.

10) Ask for evidence, not assurances

Some useful questions:

• “Show us the last 3 media fill summaries and any failures.”
• “What were your top 5 deviations last year and what changed afterward?”
• “What would make you decline this project?”
• “Where have you lost a customer relationship, and why?”
• “What are the most common causes of batch rejection at your site?”
• “Which aspects of our project are highest risk?”
• “What do you think another CDMO might do better than you?”

The quality of the answers matters as much as the content.

Practical rule of thumb

A credible and unbiased sterile fill-finish CDMO:

• proves quality with data,
• openly discusses risks and failures,
• has contamination control that matches the product risk,
• avoids overpromising,
• and is willing to recommend what is technically best, even if it is not the most profitable option for them.

If you want, I can turn this into a one-page vendor due diligence checklist or a weighted CDMO scoring template you can use in audits and RFPs.